2015
DOI: 10.4046/trd.2015.78.4.459
|View full text |Cite
|
Sign up to set email alerts
|

Progressive Pulmonary Fibrocystic Changes of Both Upper Lungs in a Patient with Ankylosing Spondylitis

Abstract: Ankylosing spondylitis is a chronic inflammatory multisystem disease that primarily affects the axial joints. Pleuropulmonary involvement is an uncommon extra-articular manifestation of ankylosing spondylitis. There is a wide spectrum of pulmonary parenchymal changes in ankylosing spondylitis, beginning in the early stages of the disease and increasing over time. The lesions are usually asymptomatic, and not visible on chest radiographs in early stages. We reported a case of advanced ankylosing spondylitis in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…Pleuropulmonary abnormalities in ankylosing spondylitis are associated with findings such as upper lobe fibrobullous disease, nonspecific interstitial changes, septal and pleural thickening [17,23]. Although proportions of interstitial pneumonias vary, nonspecific interstitial pneumonia prevailed in our patients with scleroderma and Sjögren's syndrome.…”
Section: Radiological Characteristicsmentioning
confidence: 74%
“…Pleuropulmonary abnormalities in ankylosing spondylitis are associated with findings such as upper lobe fibrobullous disease, nonspecific interstitial changes, septal and pleural thickening [17,23]. Although proportions of interstitial pneumonias vary, nonspecific interstitial pneumonia prevailed in our patients with scleroderma and Sjögren's syndrome.…”
Section: Radiological Characteristicsmentioning
confidence: 74%
“…In one study including 26 patientswith AFBD, the most frequently isolated agent was Aspergillus fumigatus , followed by various mycobacterial species (including Mycobacterium kansasii, M. avium, M. fortuitum, and M. scrofulaceum ); other studies found other Aspergillus and Candida species [ 1 , 3 , 12 ]. Chronic colonization by Aspergillus species occurs in 50–60% of the patients with AS having lung structural disease, and 10–30% of these will develop disease [ 13 , 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…Anti-bacillary treatment was performed for 9 months and concluded after confirmation of negative cultures in bronchial wash. Later, voriconazole was started to treat CCPA based on clinical, laboratory, and bronchial wash findings. AFBD, especially with cavitation features, can be erroneously diagnosed as pulmonary TB, particularly in patients under or previously submitted to AS biological treatment [ 14 ]. In the reported case, the patient had been under anti-TNF-α therapy for almost 2 years after negative TB screening and was no longer under that medication at the time of first observation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Inaccurate differential diagnosis may result in unnecessary tuberculosis therapy. In addition, secondary fungal and bacterial infections such as primarily Aspergillus may also develop in these lesions [ 4 , 5 ]. Pulmonary apical fibrosis develops in about 2 decades and progresses very slowly [ 4 , 6 ].…”
Section: Introductionmentioning
confidence: 99%